Here is the latest stock price and chart of BALAXI PHARMA. For more details, see the BALAXI PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Live BSE Quotes |
---|
Not listed |
Live NSE Quotes | Nov 29, 2023 10:32:18 AM | ||
---|---|---|---|
Price (Rs)440.00 | Open (Rs) 436.85 | High (Rs) 440.00 | Low (Rs) 425.05 |
% Change0.71 | Volume 992 | Value (Rs) 431,203 | 52-Week H/L 670.00 / 399.95 |
BSE Sensex | CNX Nifty |
BALAXI PHARMA last traded price was up 0.7% to Rs 440.0 on the NSE. The total volume of shares traded was 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.6%. And the benchmark NIFTY 50 was at 20,005.6 (up 0.6%).
Over the last 30 days, the BALAXI PHARMA share price is up 4.0%.
As of September 2023, company promoters held 71.22% stake in BALAXI PHARMA, with no shares having been pledged. To know more, check out the latest shareholding pattern of BALAXI PHARMA.
On the NSE, BALAXI PHARMA last traded price was up 0.7% at Rs 440.0.
For the financial year 2023, BALAXI PHARMA declared dividend amounting to Rs 0.0 per share. At the current price of Rs 440.0, this results in a dividend yield of 0.0%.
Based on marketcap, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks ranked by marketcap here.
Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.
Based on sales, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.
Based on net profit, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.
Asian share markets are mixed today after Australia's monthly inflation gauge snapped two months of acceleration in October 2023, bolstering the case for the Reserve Bank to resume pausing interest rates next week.